Integrated Micro-Chromatography Systems, Inc.
Irmo, SC · Founded 2012 · CIK 0001575623 · Biotech · Private
Chemoenzymatic synthesis platform for producing sialoglycans using one-pot multienzyme reactions
imcstips.com →- Grants
- $7.2M
- 9 awards
- Sector median: 1
- Raised
- $150K
- 1 Form D · May 2013
- 161 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 6 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides | $900,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Affordable sialoglycans and associated reagents for expanded chemoenzymatic production | $640,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides | $1,835,302 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides | $882,086 | |
| Federal grant | Department of Health and Human Services · Phase II · Affordable sialoglycans and associated reagents for expanded chemoenzymatic production | $1,315,355 | |
| Federal grant | Department of Health and Human Services · Phase II · Affordable sialoglycans and associated reagents for expanded chemoenzymatic production | $653,443 | |
| Federal grant | Department of Health and Human Services · Phase II · Affordable sialoglycans and associated reagents for expanded chemoenzymatic production | $644,573 | |
| Federal grant | Department of Health and Human Services · Phase II · Chemoenzymatic methods and reagents to access affordable (iso)globo- and(neo)lacto-glycosphingolipids | $315,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2646 | Ajaya Bio, Inc. | — | $150K |
| 2647 | STEMSAVE INC | — | $150K |
| 2648 | ViroMissile, Inc. | — | $150K |
| 2649 | Integrated Micro-Chromatography Systems, Inc. | — | $150K |
| 2650 | SIDERO BIOSCIENCE, LLC | — | $145K |
| 2651 | ORION THERAPEUTICS INC. | — | $145K |
| 2652 | Finch Therapeutics, Inc. | — | $4.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- LIM LEEExecutive Officer
Patents
- Automated Buffer Exchange With Gel Filtration Tips On Pressure-fit Automated Liquid Handlersapplication
- Chimeric And Other Variant Beta-glucuronidase Enzymes With Enhanced Propertiesgranted
- Variant Sulfatase Enzymes With Enhanced Propertiesgranted
- Compositions Of Beta-glucuronidase Enzyme Blends With Enhanced Enzymatic Activity And Methods Of Preparation Thereofgranted
- Chimeric And Other Variant Beta-glucuronidase Enzymes With Enhanced Propertiesgranted
- Compositions of Beta-Glucuronidase Enzyme Blends with Enhanced Enzymatic Activity and Methods of Preparation Thereofgranted
- Dispersive Pipette Extraction System For Purification Of Large Biomoleculesgranted
- Thermostabile Beta-glucuronidase Formulationsapplication
- Variant Sulfatase Enzymes With Enhanced Propertiesapplication
- Compositions Of Enzymes Blends And Methods Of Preparation Thereofapplication
- Thermostabile Beta-glucuronidase Formulationsapplication
- Chimeric And Other Variant Beta-glucuronidase Enzymes With Enhanced Propertiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.